These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21865044)

  • 1. Persistent pain after targeted intraoperative radiotherapy (TARGIT) or external breast radiotherapy for breast cancer: a randomized trial.
    Andersen KG; Gärtner R; Kroman N; Flyger H; Kehlet H
    Breast; 2012 Feb; 21(1):46-9. PubMed ID: 21865044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase III trial TARGIT-A.
    Welzel G; Boch A; Sperk E; Hofmann F; Kraus-Tiefenbacher U; Gerhardt A; Suetterlin M; Wenz F
    Radiat Oncol; 2013 Jan; 8():9. PubMed ID: 23294485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TARGIT trial: targeted intraoperative radiation therapy versus conventional postoperative whole-breast radiotherapy after breast-conserving surgery for the management of early-stage invasive breast cancer (a trial update).
    Holmes DR; Baum M; Joseph D
    Am J Surg; 2007 Oct; 194(4):507-10. PubMed ID: 17826067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health economics of targeted intraoperative radiotherapy (TARGIT-IORT) for early breast cancer: a cost-effectiveness analysis in the United Kingdom.
    Vaidya A; Vaidya P; Both B; Brew-Graves C; Bulsara M; Vaidya JS
    BMJ Open; 2017 Aug; 7(8):e014944. PubMed ID: 28819067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early initiation of external beam radiotherapy (EBRT) may increase the risk of long-term toxicity in patients undergoing intraoperative radiotherapy (IORT) as a boost for breast cancer.
    Wenz F; Welzel G; Keller A; Blank E; Vorodi F; Herskind C; Tomé O; Sütterlin M; Kraus-Tiefenbacher U
    Breast; 2008 Dec; 17(6):617-22. PubMed ID: 18650091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient preferences for adjuvant radiotherapy in early breast cancer are strongly influenced by treatment received through random assignment.
    Corica T; Saunders CM; Bulsara MK; Taylor M; Joseph DJ; Nowak AK
    Eur J Cancer Care (Engl); 2019 Mar; 28(2):e12985. PubMed ID: 30637839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis.
    Pignol JP; Olivotto I; Rakovitch E; Gardner S; Sixel K; Beckham W; Vu TT; Truong P; Ackerman I; Paszat L
    J Clin Oncol; 2008 May; 26(13):2085-92. PubMed ID: 18285602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental and social benefits of the targeted intraoperative radiotherapy for breast cancer: data from UK TARGIT-A trial centres and two UK NHS hospitals offering TARGIT IORT.
    Coombs NJ; Coombs JM; Vaidya UJ; Singer J; Bulsara M; Tobias JS; Wenz F; Joseph DJ; Brown DA; Rainsbury R; Davidson T; Adamson DJ; Massarut S; Morgan D; Potyka I; Corica T; Falzon M; Williams N; Baum M; Vaidya JS
    BMJ Open; 2016 May; 6(5):e010703. PubMed ID: 27160842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boost.
    Vaidya JS; Baum M; Tobias JS; Massarut S; Wenz F; Murphy O; Hilaris B; Houghton J; Saunders C; Corica T; Roncadin M; Kraus-Tiefenbacher U; Melchaert F; Keshtgar M; Sainsbury R; Douek M; Harrison E; Thompson A; Joseph D
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1335-8. PubMed ID: 17084562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative radiotherapy in early breast cancer.
    Esposito E; Anninga B; Harris S; Capasso I; D'Aiuto M; Rinaldo M; Douek M
    Br J Surg; 2015 May; 102(6):599-610. PubMed ID: 25787293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative seroma formation after intraoperative radiotherapy using low-kilovoltage X-rays given during breast-conserving surgery.
    Kraus-Tiefenbacher U; Welzel G; Brade J; Hermann B; Siebenlist K; Wasser KS; Schneider FS; Sütterlin M; Wenz F
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1140-5. PubMed ID: 19836152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cosmesis and Breast-Related Quality of Life Outcomes After Intraoperative Radiation Therapy for Early Breast Cancer: A Substudy of the TARGIT-A Trial.
    Corica T; Nowak AK; Saunders CM; Bulsara M; Taylor M; Vaidya JS; Baum M; Joseph DJ
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):55-64. PubMed ID: 27511847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of pain and emotional characteristics of women after surgery for breast cancer.
    Sheridan D; Foo I; O'Shea H; Gillanders D; Williams L; Fallon M; Colvin L
    J Pain Symptom Manage; 2012 Oct; 44(4):608-14. PubMed ID: 22743155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective trial of intraoperative radiation treatment for breast cancer.
    Joseph DJ; Bydder S; Jackson LR; Corica T; Hastrich DJ; Oliver DJ; Minchin DE; Haworth A; Saunders CM
    ANZ J Surg; 2004 Dec; 74(12):1043-8. PubMed ID: 15574144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematical modelling of radiotherapy strategies for early breast cancer.
    Enderling H; Anderson AR; Chaplain MA; Munro AJ; Vaidya JS
    J Theor Biol; 2006 Jul; 241(1):158-71. PubMed ID: 16386275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fat necrosis after conserving surgery and interstitial brachytherapy and/or external-beam irradiation in women with breast cancer.
    Ott OJ; Schulz-Wendtland R; Uter W; Pfahlberg A; Beckmann MW; Sauer R; Strnad V
    Strahlenther Onkol; 2005 Oct; 181(10):638-44. PubMed ID: 16220402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors of developing long-lasting breast pain after breast cancer radiotherapy.
    Lundstedt D; Gustafsson M; Steineck G; Malmström P; Alsadius D; Sundberg A; Wilderäng U; Holmberg E; Johansson KA; Karlsson P
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):71-8. PubMed ID: 22079722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience.
    Ling SM; Roach M; Fu KK; Coleman C; Chan A; Singer M
    Cancer J Sci Am; 1996; 2(6):321-9. PubMed ID: 9166552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptoms 10-17 years after breast cancer radiotherapy data from the randomised SWEBCG91-RT trial.
    Lundstedt D; Gustafsson M; Malmström P; Johansson KA; Alsadius D; Sundberg A; Wilderäng U; Holmberg E; Anderson H; Steineck G; Karlsson P
    Radiother Oncol; 2010 Nov; 97(2):281-7. PubMed ID: 20970212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation.
    Johansen J; Overgaard J; Overgaard M
    Acta Oncol; 2007; 46(4):525-33. PubMed ID: 17497320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.